597: Protocol development for mouse toxicology studies using lentiviral gene therapy by Sinadinos, A, Meng, C, Gamlen, T, Hyde, S, Gill, D, Alton, E, Griesenbach, U

Exploring the mechanisms of macrolides in cystic fibrosis. by Equi, A, Davies, J, Painter, H, Hyde, S, Bush, A, Geddes, D, Alton, E

Development of protocols for mouse GLP-toxicology studies by Sinadinos, A, Sergijenko, A, Meng, C, Gamlen, T, Hyde, S, Gill, D, Griesenbach, U, Alton, E

EXERCISE CAPACITY AND PHYSICAL ACTIVITY IN PATIENTS WITH CF: DATA FROM THE UK CF GENE THERAPY CONSORTIUM (UKCFGTC) 'RUN-IN' STUDY by Saunders, C, Davies, G, Bell, N, Reid, P, Sheridan, H, Hyde, S, Innes, J, Alton, E

LONGITUDINAL ASSESSMENT OF BIOMARKERS FOR CLINICAL TRIALS OF NOVEL THERAPEUTIC AGENTS: THE RUN-IN STUDY by Alton, E, Boyd, C, Cunningham, S, Davies, J, Hyde, S, Ianes, J, Gill, D, Greening, A, Griesenbach, U, Higgins, T, Porteous, D

Assessment of CFTR function after gene transfer in vitro and in vivo. by Griesenbach, U, Munkonge, F, Sumner-Jones, S, Holder, E, Smith, SN, Boyd, A, Gill, DR, Hyde, S, Porteous, D, Alton, E

Optimisation of adenoviral and plasmid-mediated gene transfer to the murine myocardium by Griesenbach, U, Darlay, R, Marshall, N, Dean, P, Williams, J, Zhu, J, Jeffery, P, Gill, D, Geddes, D, Alton, E

Genetic medicines for CF: Hype versus reality by Alton, E, Boyd, A, Davies, J, Gill, D, Griesenbach, U, Harrison, P, Henig, N, Higgins, T, Hyde, S, Innes, J, Korman, M

A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis by Alton, E, Boyd, A, Cheng, S, Cunningham, S, Davies, J, Gill, DR, Griesenbach, U, Higgins, T, Hyde, S, Innes, J, Murray, G, Porteous, D

EVALUATION OF SAFETY AND GENE EXPRESSION WITH A SINGLE DOSE OF PGM169/GL67A ADMINISTERED TO THE NOSE AND LUNG OF INDIVIDUALS WITH CF: THE UK CF GENE THERAPY CONSORTIUM "PILOT STUDY... by Davies, J, Gill, D, Griesenbach, U, Voase, N, Davies, G, Higgins, T, Innes, J, Boyd, C, Porteous, D, Hyde, S, Alton, E

EVALUATION OF SAFETY AND GENE EXPRESSION WITH A SINGLE DOSE OF PGM169/GL67A ADMINISTERED TO THE NOSE AND LUNG OF INDIVIDUALS WITH CYSTIC FIBROSIS: THE UK CF GENE THERAPY CONSORTIUM... by Davies, J, Davies, G, Voase, N, Hyde, S, Innes, A, Boyd, C, Porteous, D, Higgins, T, Griesenbach, U, Gill, D, Alton, E

Update on the UK CF Gene Therapy Consortium Multidoes, non-viral, gene therapy trial by Alton, E, Boyd, A, Cheng, S, Cunningham, S, Davies, J, Gill, DR, Griesenbach, U, Higgins, T, Hyde, S, Innes, J, Murray, G, Poteous, D

Optimisation of gene transfer to the murine myocardium by Griesenbach, U, Darlay, R, Marshall, N, Dean, P, Williams, J, Zhu, J, Jeffery, P, Gill, D, Geddes, D, Alton, E

A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis. by Alton, E, Boyd, A, Cheng, S, Cunningham, S, Davies, J, Gill, DR, Griesenbach, U, Higgins, T, Hyde, S, Innes, J, Murray, G, Porteous, D

SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CYSTIC FIBROSIS by Davies, G, Davies, J, Gill, DR, Hyde, S, Boyd, C, Innes, J, Porteous, D, Cheng, S, Scheule, R, Higgins, T, Griesenbach, U, Alton, E

Pre-existing immunity to human parainfluenza virus (hPIV) does not affect rSIV.F/HN-mediated transduction efficiency by Pytel, K, Chan, M, Meng, C, Martinez, A, Boyd, C, Davies, J, Gill, D, Hyde, S, Innes, A, Alton, E, Griesenbach, U

LONGITUDINAL ASSESSMENT OF BIOMARKERS FOR CLINICAL TRIALS OF NOVEL THERAPEUTIC AGENTS; THE RUN-IN STUDY by Alton, E, Boyd, C, Cunningham, S, Davies, J, Hyde, S, Innes, J, Gill, DR, Greening, A, Griesenbach, U, Higgins, T, Porteous, D, Consortium, UKCFGT

Recombinant Sendai virus vector to evaluate vector distribution in a large animal model of lung gene transfer by McLachlan, G, Griesenbach, U, Owaki, T, Hillery, L, Williams, J, Tsugumine, S, Boyd, C, Gill, D, Hasegawa, M, Alton, E, Collie, D

Gene therapy for pulmonary alveolar proteinosis by Atsumi, N, Pilou, A, Pringle, I, Ashworth, R, Meng, C, Chan, M, Gill, D, Hyde, S, Morgan, C, Alton, E, Griesenbach, U

SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CF by Davies, J, Davies, G, Gill, D, Hyde, S, Boyd, C, Innes, J, Porteous, D, Cheng, S, Scheule, R, Higgins, T, Griesenbach, U, Alton, E